Impact of shortages of injectable oncology drugs on patient care

American Journal of Health-System Pharmacy

Volumn 71, Issue 7, 2014, Pages 571-578

  Goldsack, Jennifer C ^a   Reilly, Cynthia ^b   Bush, Colleen ^c   McElligott, Sean ^d   Bristol, Mirar N ^e   Motanya, U Nkiru ^f   Field, Robert ^g   Vozniak, J Michael ^h   Wong, Yu Ning ^i,j   Schwartz, J Sanford ^d   Domchek, Susan ^f  

^a CHRISTIANA CARE HEALTH SYSTEM   (United States)

^b Medication Safety and Quality Division   (United States)

^c AMERICAN SOCIETY OF HEALTH SYSTEM PHARMACISTS   (United States)

^d Division of General Internal Medicine   (United States)

^e General Internal Medicine   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g DREXEL UNIVERSITY   (United States)

^h HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ Medical Oncology   (United States)

^j FOX CHASE CANCER CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; DRUG COST; DRUG MANUFACTURE; DRUG SHORTAGE; HEALTH CARE; HEALTH CARE SURVEY; HUMAN; PATIENT CARE; PATIENT REFERRAL; PATIENT SAFETY; PHARMACY; PURCHASING; THERAPY DELAY; INJECTION; SUPPLY AND DISTRIBUTION;

ANTINEOPLASTIC AGENTS; DRUG COSTS; HUMANS; INJECTIONS; PATIENT CARE;

EID: 84907220444     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp130569     Document Type: Article

References (29)

1. American Society of Health-System Pharmacists. Drug shortages: current drugs. www.ashp.org/menu/DrugShortages/CurrentShortages (accessed 2013 Nov 14).
2. Crosse M, Government Accountability Office. Drug shortages: FDA's ability to respond should be strengthened. Testimony before U.S. Senate Committee on Health, Education, Labor and Pensions, U.S. Senate. 2011 Dec 15.
3. Devi S. U.S. drug shortages could continue for years. Lancet. 2012; 379:990-1.
4. American Society of Health-System Pharmacists. National drug shortage statistics. www.ashp.org/DocLibrary/Policy/DrugShortages/Drug-Shortages-Statistics.pdf (accessed 2013 Jan 13).
5. MediLexicon International Ltd. Cancer drugs and oncology drugs. www.medilexicon.com/drugs-list/cancer.php (accessed 2013 Jun 10).
6. MacDonald EA, Fox ER, Tyler LS. Drug shortages: process for evaluating impact on patient safety. Hosp Pharm. 2011; 46:943-51.
7. Fox ER. Drug shortages: keep it safe! www.ashpmedia.org/symposia/generics/presentations/resources/handout-fox.pdf (accessed 2014 Jan 8).
8. Institute for Safe Medication Practices. National survey on drug shortages reveals serious impact on patient safety (September 23, 2010). www.ismp.org/pressroom/PR20100923.pdf (accessed 2013 Jun 2).
9. Metzger ML, Billett A, Link MP. The impact of drug shortages on children with cancer - the example of mechlorethamine. N Engl J Med. 2012; 367: 2461-3.
10. Printz C. Medication shortages threaten cancer care: the oncology community and the FDA tackle ongoing drug shortage problem. Cancer. 2012; 118:289-91.
11. Summary of a stakeholders' meeting on drug shortages convened by the American Medical Association and the American Society of Health-System Pharmacists. Provisional observations on drug product shortages: effects, causes and potential solutions. Am J Health-Syst Pharm. 2002; 59:2173-82.
12. Chan-Tompkins NH, Curinga R, Fera T. Surviving drug shortages: a perspective from the hospital pharmacy. P&T. 2002; 27:117-9.
13. Kaakeh R, Sweet BV, Reilly C et al. Impact of drug shortages on U.S. health systems. Am J Health-Syst Pharm. 2011; 68:1811-9.
14. McBride A, Holle LM, Westendorf C et al. National survey on the effect of oncology drug shortages on cancer care. Am J Health-Syst Pharm. 2013; 70:609-17.
15. Emanuel EJ, Shuman K, Chinn D et al. Impact of oncology drug shortages. J Clin Oncol. 2013; 31(suppl):abstract CRA6510.
16. American Association for Cancer Research. Cancer policy monitor, March 2012. www.aacr.org/home/public-media/science-policy-governmentaffairs/aacr-cancer-policy-monitor/aacrcancer-policy-monitor-march-2012/advocacy-leaders-analyze-growing-drugshortage-problem.aspx (accessed 2013 Aug 29).
17. Kweder SL, Dill S. Drug shortages: the cycle of quantity and quality. Clin Pharmacol Ther. 2013; 93:245-51.
18. Woodcock J, Wosinska M. Economic and technological drivers of generic sterile injectable drug shortages. Clin Pharmacol Ther. 2013; 93:170-6.
19. Willis GB. Cognitive interviewing. A "how to" guide. http://appliedresearch.cancer.gov/areas/cognitive/interview.pdf (accessed 2013 Aug 29).
20. American Hospital Association. Fast facts on US hospitals, 2013. www.aha.org/research/rc/stat-studies/fast-facts.shtml (accessed 2013 Jul 13).
21. Agency for Healthcare Research and Quality. Hospital survey on patient safety culture: 2012 comparative database report. www.ahrq.gov/legacy/qual/hospsurvey12/hosp12tab3-1.htm (accessed 2014 Jan 8).
22. American Society of Health-System Pharmacists. Legislative summary: drug shortages provisions within the Food and Drug Administration Safety and Innovation Act (S. 3187). May 9, 2012. www.ashp.org/DocLibrary/Advocacy/GAD/Reauthorization-of-PDUFA.aspx (accessed 2013 Aug 30).
23. Food and Drug Administration. For industry: generic drug user fee amendments of 2012. www.fda.gov/ForIndustry/UserFees/GenericDrugUserFees/default.htm (accessed 2013 Aug 30).
24. Business Wire. Independent survey of US oncologists by national analysts worldwide finds drug shortages and escalating costs result in grave health consequences. www.businesswire.com/news/home/20120201005292/en/Independent-Survey-Oncologists-National-Analysts-Worldwide-Finds (accessed 2013 Aug 30).
25. Manolakis M. Ethical integrity in managing drug shortages. Am J Health-Syst Pharm. 2012; 69:17. Editorial.
26. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology - colon cancer, version 3.2013. www.tri-kobe.org/nccn/guideline/colorectal/english/colon.pdf (accessed 2013 Nov 8).
27. Valgus J, Singer EA, Berry SR et al. Ethical challenges: managing oncology drug shortages. J Oncol Pract. 2013; 9:e21-3.
28. Simon S, American Cancer Society. Cancer drug shortages concern doctors and patients. www.cancer.org/cancer/news/chemotherapy-drug-shortages-concerndoctors-and-patients (accessed 2013 Aug 29).
29. Mullins CD, Montgomery R, Tunis S. Proposed recommendations for designing clinical trials for "new indications"of approved oncology drugs for treatment of late stage disease. www.cmtpnet.org/wp-content/uploads/downloads/2012/02/NewIndicationsEGD.pdf (accessed 2013 Nov 11).